Drucken
Artikel, Notizen und Markierungen werden geladen... Bitte um etwas Geduld.

Federal Act
on Medicinal Products and Medical Devices
(Therapeutic Products Act, TPA)

Art. 10 Conditions for granting a marketing authorisation

1 Any per­son ap­ply­ing for a mar­ket­ing au­thor­isa­tion must:43

a.44
prove that the medi­cin­al products with in­dic­a­tions or pro­ced­ures are of high qual­ity and are safe and ef­fect­ive;
abis.45
in the case of com­ple­ment­ary medi­cines without in­dic­a­tion, at any time on the basis of doc­u­ment­a­tion:
1.
prove that they are of high qual­ity, and
2.
cred­ibly demon­strate that the medi­cin­al product in ques­tion does not pose a risk to the safety of con­sumers;
b.
be a hold­er of an au­thor­isa­tion to man­u­fac­ture, im­port or con­duct whole­sale trade is­sued by the com­pet­ent au­thor­ity;
c.
have a re­gistered ad­dress, re­gistered of­fice or a branch of­fice in Switzer­land.

2 The Agency shall veri­fy that the con­di­tions for grant­ing the mar­ket­ing au­thor­isa­tion are ful­filled. To this ef­fect, it may carry out product-spe­cif­ic in­spec­tions.

43 Amended by No I of the FA of 18 March 2016, in force since 1 Jan. 2019 (AS 2017 2745, 2018 3575; BBl 2013 1).

44 Amended by No I of the FA of 18 March 2016, in force since 1 Jan. 2019 (AS 2017 2745, 2018 3575; BBl 2013 1).

45 In­ser­ted by No I of the FA of 18 March 2016, in force since 1 Jan. 2019 (AS 2017 2745, 2018 3575; BBl 2013 1).